Meeting
2018 Genitourinary Cancers Symposium
Can free PSA be used as a biomarker in biochemical recurrence after surgery to predict castrate resistant prostate cancer?
Authors
Hanan Goldberg
Princess Margaret Cancer Center, Toronto, ON, Canada
Hanan Goldberg , Ally Hoffman , Teck Sing Woon , Zachary William Abraham Klaassen , Thenappan Chandrasekar , Douglas Cheung , Alejandro Berlin , Rashid Sayyid , Neil Eric Fleshner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 177)
DOI
10.1200/JCO.2018.36.6_suppl.177
Abstract #
177
Poster Bd #
H17
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Targeting mediator subunits CDK8/CDK19 for treatment of advanced prostate cancer.
First Author: Marie C. Hupe
Poster
2024 ASCO Genitourinary Cancers Symposium
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.
First Author: Ekamjit Singh Deol
Poster
2024 ASCO Genitourinary Cancers Symposium
ERBB3 expression in racially diverse patients with castration-sensitive prostate cancer and its association with a unique AR activity signature.
First Author: Jordan Vellky
Poster
2023 ASCO Genitourinary Cancers Symposium
Prognostic biomarkers and clinical outcomes in neuroendocrine prostate cancer (NEPC).
First Author: Richard Gagnon